Get started
Author

Ju. V. Rybachkova

Observed names: J. V. Rybachkova, JV Rybachkova
ORCID: 0000-0001-8041-8770
Observed ORCIDs: 0000-0001-8041-8770, 0000-0002-8602-9554
OpenAlex ID: A5070432292
Pharmacogenetic Features of Therapy of Patients With Atherosclerosis
2018 · A. L. Khokhlov, A. N. Yavorsky, et al. · The Russian Archives of Internal Medicine · 6
PDF
Efficacy and safety of pirfenidone according to clinical trials
2024 · A. L. Khokhlov, J. V. Rybachkova · Patient-Oriented Medicine and Pharmacy · 2
PDF
Aspects of the safety of hypoglycemic drugs according to the results of clinical trials
2023 · A. L. Khokhlov, K. V. Gorelov, et al. · Patient-Oriented Medicine and Pharmacy · 2
PDF
To the assessment of the use of sugar-reducing drugs from the position of safety
2023 · A. L. Khokhlov, K. V. Gorelov, et al. · Patient-Oriented Medicine and Pharmacy · 2
PDF
The use of a new oral antiviral drug molnupiravir in the treatment of COVID-19 from a safety perspective
2022 · A. L. Khokhlov, J. V. Rybachkova · Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice · 1
PDF
Amisulpride from the standpoint of efficacy and safety
2025 · A. L. Khokhlov, Ju. V. Rybachkova · Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
PDF
Focus on lomefloxacin: effectiveness and safety
2024 · A. L. Khokhlov, Ju. V. Rybachkova · Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
Bioethical approach to estimation of pharmacoepidemiological and pharmacoeconomic aspects of psoriasis treatment
2024 · EI Samarina, EG Lileeva, et al. · Медицинская этика
PDF
Hydroxyethylammonium methylphenoxyacetate, immunomodulator and adaptogen: clinical use review
2022 · JV Rybachkova · Медицинская этика
PDF
Works count: 9
Citation count: 13
H-index: 2
I10-index:
Year
Topic
Type